VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673,920 | -34.4% | 156,000 | 0.0% | 0.13% | -31.7% |
| Q2 2023 | $1,028,040 | -2.9% | 156,000 | 0.0% | 0.19% | +13.9% |
| Q1 2023 | $1,059,240 | -8.1% | 156,000 | 0.0% | 0.17% | -11.7% |
| Q4 2022 | $1,152,840 | -25.2% | 156,000 | 0.0% | 0.19% | -29.3% |
| Q3 2022 | $1,541,000 | -9.4% | 156,000 | 0.0% | 0.27% | -9.2% |
| Q2 2022 | $1,700,000 | -3.6% | 156,000 | 0.0% | 0.29% | -14.6% |
| Q1 2022 | $1,764,000 | -27.9% | 156,000 | 0.0% | 0.34% | -36.1% |
| Q4 2021 | $2,448,000 | +15.2% | 156,000 | +25.8% | 0.54% | +14.7% |
| Q3 2021 | $2,125,000 | +6.2% | 124,000 | +33.3% | 0.47% | +13.0% |
| Q2 2021 | $2,000,000 | +85.0% | 93,000 | +29.2% | 0.41% | +85.7% |
| Q1 2021 | $1,081,000 | +61.3% | 72,000 | +41.2% | 0.22% | +26.7% |
| Q4 2020 | $670,000 | +98.2% | 51,000 | +45.7% | 0.18% | +97.8% |
| Q3 2020 | $338,000 | – | 35,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |